Juan Vaz

Lund University

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Anders Helander

Karolinska University Hospital

SWEDEN

View details

Emilie Toresson Grip

Karolinska Institutet

SWEDEN

View details

Rickard Strandberg

Karolinska Institutet

SWEDEN

View details

Patrik Midlöv

Lund University

SWEDEN

View details

Mary E. Rinella

University of Chicago Pritzker School of Medicine

UNITED STATES

View details

Axel Wester

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Juan Vaz

Research Interests

Explore related searches

Contact this professor

Articles (14)

Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes

Socioeconomic disparities in incidence, treatment, and survival of intrahepatic cholangiocarcinoma: insights from a nationwide cohort study in Sweden

Phosphatidylethanol for monitoring alcohol use after liver transplantation

Reply to: “Why one PEth result cannot redraw the MASLD/ALD boundary: A single-snapshot misclassification” and “Phosphatidylethanol-guided reclassification of steatotic liver disease subgroups improves prognostic stratification: Greater precision is required”

The People-First Liver Charter.

Non-liver comorbidity in patients with hepatocellular carcinoma and curative treatments – a Swedish national registry study

Socioeconomic inequalities in diagnostics, care and survival outcomes for hepatocellular carcinoma in Sweden: a nationwide cohort study

Addressing the impact of stigma in liver diseases: A call for proper language and responsibility allocation

Metabolic dysfunction‐associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: A nationwide cohort study

Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients

Targeting population groups with heavier burden of hepatocellular carcinoma incidence: A nationwide descriptive epidemiological study in Sweden

NAFLD cirrhosis in Sweden

Socioeconomic and marital status among liver cirrhosis patients and associations with mortality: a population-based cohort study in Sweden

Incidence, aetiology and related comorbidities of cirrhosis

Collaborators (6)

Anders Helander

Emilie Toresson Grip

Rickard Strandberg

Patrik Midlöv

Mary E. Rinella

Axel Wester

Make your next move.